Brief Research Report
Published on 24 Sep 2025
Exploring the binding sites of VRT534 at Cx26 as a putative chemical chaperone for targeted treatment of hereditary hearing disorders
in Precision Medicine
Frontiers in Medicine
doi 10.3389/fmed.2025.1607598
- 1,315 views



